Back to Search Start Over

1122P An adjusted comparison of amivantamab phase II data versus real-world clinical management in France of EGFR exon 20 insertion-mutated (ex20ins) advanced NSCLC patients

Authors :
C. Chouaid
N. Perualila
D. Debieuvre
X. Quantin
J. Diels
N. Rahhali
R. Toueg
G. Simon
L. Bosquet
T. Filleron
Source :
Annals of Oncology. 33:S1064-S1065
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Oncology
Hematology

Details

ISSN :
09237534
Volume :
33
Database :
OpenAIRE
Journal :
Annals of Oncology
Accession number :
edsair.doi...........818a464dec4d39371d34fcff53779dbb

Tools

Authors Abstract Subjects Details